biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > A Little STFU Story

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Oct 05, 2022 12:16pm

136 Views

Post# 35006883

RE:A Little STFU Story

I think there is a good chance Bioasis will eventually be successful and worth big bucks. The big question is whether existing shareholders will get through the start of the Phase II trial and the NASDAQ listing without crippling dilution.

There is a lot that is not visible to shareholders of course, but IMO, unless we see the start of a clinical trial soon, I don't see any other maneuvering that will save us.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages